Tenascin-C and human tendon degeneration.

Fibrocartilage in tendons and ligaments--an adaptation to compressive load. J Anat (1998) 2.77

The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal (2009) 1.72

The basic science of tendinopathy. Clin Orthop Relat Res (2008) 1.37

The vasculature and its role in the damaged and healing tendon. Arthritis Res (2002) 1.35

Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems. BMC Musculoskelet Disord (2009) 1.09

The pathogenesis of tendinopathy: balancing the response to loading. Nat Rev Rheumatol (2010) 1.07

The role of the non-collagenous matrix in tendon function. Int J Exp Pathol (2013) 1.01

Spatial and temporal expression of molecular markers and cell signals during normal development of the mouse patellar tendon. Tissue Eng Part A (2011) 1.01

The influence of collagen-glycosaminoglycan scaffold relative density and microstructural anisotropy on tenocyte bioactivity and transcriptomic stability. J Mech Behav Biomed Mater (2011) 1.00

Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds. Tissue Eng Part A (2013) 0.97

Expression of transforming growth factor-beta isoforms and their receptors in chronic tendinosis. J Anat (2001) 0.92

Deciphering the pathogenesis of tendinopathy: a three-stages process. Sports Med Arthrosc Rehabil Ther Technol (2010) 0.91

Micro-scale and meso-scale architectural cues cooperate and compete to direct aligned tissue formation. Biomaterials (2014) 0.83

In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regeneration. Tissue Eng Part A (2015) 0.83

Defects in tendon, ligament, and enthesis in response to genetic alterations in key proteoglycans and glycoproteins: a review. Arthritis (2013) 0.82

Gene expression of tendon markers in mesenchymal stromal cells derived from different sources. BMC Res Notes (2014) 0.82

Expression and degeneration of tenascin-C in human lung cancers. Br J Cancer (1998) 0.81

Recombinant human adiponectin as a potential protein for treating diabetic tendinopathy promotes tenocyte progenitor cells proliferation and tenogenic differentiation in vitro. Int J Med Sci (2013) 0.77

Cellular distribution and gene expression profile during flexor tendon graft repair: A novel tissue engineering approach(*). J Tissue Eng (2013) 0.76

A study of the distribution of color Doppler flows in the superficial digital flexor tendon of young Thoroughbreds during their training periods. J Equine Sci (2016) 0.75

The roles of Tenascin C and Fibronectin 1 in adhesive capsulitis: a pilot gene expression study. Clinics (Sao Paulo) (2016) 0.75

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71

Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol (1973) 33.51

Induction of tenascin in healing wounds. J Cell Biol (1988) 2.45

Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol (1984) 2.10

Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell (1989) 2.01

Rotator cuff disease of the shoulder. J Bone Joint Surg Am (1985) 2.01

Structural specialization in tendons under compression. Int Rev Cytol (1989) 1.91

The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development (1991) 1.90

Cell-matrix response in tendon injury. Clin Sports Med (1992) 1.87

Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol (1987) 1.80

STRUCTURE AND FUNCTION OF MAMMALIAN TENDON. Biol Rev Camb Philos Soc (1965) 1.79

Tenascin is increased in cartilage and synovium from arthritic knees. Br J Rheumatol (1993) 1.75

Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol (1991) 1.73

Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73

Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58

Molecular forms, binding functions, and developmental expression patterns of cytotactin and cytotactin-binding proteoglycan, an interactive pair of extracellular matrix molecules. J Cell Biol (1988) 1.56

Development and ageing of phenotypically distinct fibrocartilages associated with the rat Achilles tendon. Anat Embryol (Berl) (1992) 1.55

Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1994) 1.43

An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sci U S A (1989) 1.41

Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J Cell Biol (1991) 1.36

The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell (1994) 1.35

Regional expression of mRNA for proteoglycans and collagen in tendon. Eur J Cell Biol (1994) 1.24

Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. Ann Rheum Dis (1995) 1.22

Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem (1995) 1.19

Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol (1994) 1.14

Tenascin distribution in articular cartilage from normal subjects and from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1994) 1.10

Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J Cell Sci (1994) 1.06

Flexor tendon repair in vitro: a comparative histologic study of the rabbit, chicken, dog, and monkey. J Orthop Res (1984) 1.06

Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul (1991) 1.03

Enhanced expression of neural cell adhesion molecules and tenascin (cytotactin) during wound healing. Am J Pathol (1991) 0.99

Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci (1992) 0.92

Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. Cancer Res (1991) 0.92

A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res (1993) 0.89

Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Adhes Commun (1994) 0.88

Expression of tenascin in joint-associated tissues during development and postnatal growth. J Anat (1996) 0.88

Tendon lesions and soft tissue rheumatism--great outback or great opportunity? Ann Rheum Dis (1996) 0.87

Roles of adhesion molecules NCAM and tenascin in limb skeletogenesis: analysis with antibody perturbation, exogenous gene expression, talpid mutants and activin stimulation. Prog Clin Biol Res (1993) 0.82

Immunohistochemical studies on tenascin in human yellow ligament. In Vivo (1993) 0.78

Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell (1986) 4.10

Shoulder disorders in the elderly: a community survey. Arthritis Rheum (1991) 3.21

A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem (1979) 3.17

Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14

Supervision of epileptic patients taking phenytoin. Br Med J (1970) 3.09

Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis (1981) 3.08

Thermographic changes in keyboard operators with chronic forearm pain. BMJ (1997) 2.90

Frozen shoulder: a long-term prospective study. Ann Rheum Dis (1984) 2.67

Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease. J Rheumatol (1974) 2.66

Frozen shoulder: prospective clinical study with an evaluation of three treatment regimens. Ann Rheum Dis (1984) 2.60

Shoulder disorders in the elderly (a hospital study). Ann Rheum Dis (1987) 2.45

Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial. J Orthop Res (2002) 2.40

Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res (2003) 2.38

The painful stiff shoulder. Rheumatol Phys Med (1972) 2.37

Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17

Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12

Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94

A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol (1990) 1.87

Wound healing after operations of patients with rheumatoid arthritis. J Bone Joint Surg Br (1973) 1.86

Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A (1987) 1.81

Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis (1989) 1.81

Tennis elbow--a reappraisal. Br J Rheumatol (1989) 1.76

Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol (1997) 1.76

Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis (1989) 1.74

An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford) (2002) 1.74

Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73

The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72

Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet (1992) 1.72

Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. J Bone Joint Surg Br (2002) 1.71

The long-term outcome of rotator cuff tendinitis--a review study. Br J Rheumatol (1988) 1.69

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum (2001) 1.67

Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis (1989) 1.66

Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol (1997) 1.64

Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62

The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1993) 1.62

Diagnosis and relation to general health of shoulder disorders presenting to primary care. Rheumatology (Oxford) (2005) 1.61

Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58

Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57

Fragments of human fibroblast collagenase. Purification and characterization. Biochem J (1989) 1.55

Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis (1987) 1.54

Purification of pig synovial collagenase to high specific activity. Biochem J (1979) 1.53

An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J (1981) 1.52

The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum (2002) 1.52

Lateral humeral epicondylitis--a study of natural history and the effect of conservative therapy. Br J Rheumatol (1983) 1.46

Is therapeutic ultrasound effective in treating soft tissue lesions? Br Med J (Clin Res Ed) (1985) 1.46

Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure (1995) 1.44

Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1994) 1.43

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis (1986) 1.42

Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41

Immunological studies in frozen shoulder. J Rheumatol (1983) 1.38

Variegated transfer of recombinant glycosylphosphatidylinositol-anchored CD4 among cultured cells: correlation of flow cytometric and microscopic observations. J Lab Clin Med (1998) 1.37

Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun (2001) 1.35

Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer (1991) 1.34

Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax (2005) 1.33

Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum (2001) 1.31

Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum (1984) 1.31

Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis (2002) 1.31

Community survey of shoulder disorders in the elderly to assess the natural history and effects of treatment. Ann Rheum Dis (1995) 1.31

Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) (2005) 1.30

HLA-B27 and frozen shoulder. Lancet (1976) 1.29

A double-blind trial comparing subacromial methylprednisolone and lignocaine in acute rotator cuff tendinitis. Br J Rheumatol (1993) 1.26

Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev Biol (1988) 1.26

Calcific tendinitis of the shoulder. N Engl J Med (1999) 1.25

Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis Rheum (2001) 1.24

Immunological and histological study of temporal arteries. Ann Rheum Dis (1978) 1.24

Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J (2005) 1.23

Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23

Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci (1986) 1.22

Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. Ann Rheum Dis (1995) 1.22

Frozen shoulder: an arthrographic and radionuclear scan assessment. Ann Rheum Dis (1984) 1.20

Factors relating to circulating immune complexes in rheumatoid arthirits. Ann Rheum Dis (1976) 1.20

Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis (1985) 1.20

Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis (2008) 1.19

Shoulder pain in a community-based rheumatology clinic. Br J Rheumatol (1995) 1.17

Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett (1998) 1.16

Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum (2003) 1.15

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans. Clin Exp Immunol (1996) 1.15

Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg Br (2001) 1.14

Long-term azathioprine in rheumatoid arthritis: a double-blind study. Ann Rheum Dis (1981) 1.13

Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum (2001) 1.13

Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis (1981) 1.13

Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. Biochim Biophys Acta (1982) 1.13

Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol (1996) 1.12

Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond) (1995) 1.12